A. K. A. Wijewickrama - Infectious Diseases

Author Information

Ananda Wijewickrama is a researcher affiliated with the National Institute of Infectious Diseases in Angoda, Sri Lanka. Their work primarily focuses on the study of infectious diseases, with particular emphasis on dengue and COVID-19. Ananda Wijewickrama has contributed significantly to the understanding of immune responses and disease dynamics in these areas, which are of critical importance in regions like Sri Lanka.

Research Contributions

Ananda Wijewickrama has made substantial contributions to the field of infectious diseases, particularly in understanding the clinical and immunological aspects of dengue and COVID-19. In 2022, some of their notable research included studies on the association of rotational thromboelastometry with bleeding in dengue infections and the identification of CD4+CD8+ double-positive T cells associated with plasma leakage risk in dengue viral infections. Their work also extends to analyzing the immune response kinetics to SARS-CoV-2 proteins and investigating the transcriptomics of acute DENV-specific CD8+ T cells. Ananda's research is crucial in informing treatment protocols and understanding disease progression in resource-limited settings like Sri Lanka.

Aliases

Ananda Wijewickrama is also known by several aliases, including A Wijewickrama, A. K. A. Wijewickrama, and A. Wijewickrama. These variations may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Papers	88
Total Citations	1802
h-index	18

Publications:

Rotational thromboelastometry in critical phase of dengue infection: Association with bleeding

DOI: 10.1002/rth2.12704

Year: 2022

A Population of CD4+CD8+ Double-Positive T Cells Associated with Risk of Plasma Leakage in Dengue Viral Infection

DOI: 10.3390/v14010090

Year: 2022

Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222

DOI: 10.1093/cei/uxac009

Year: 2022

Transcriptomics of Acute DENV-Specific CD8+ T Cells Does Not Support Qualitative Differences as Drivers of Disease Severity

DOI: 10.3390/vaccines10040612

Year: 2022

Applicability of protocols from high-income countries in a resource limited setting; real world data of histopathology, clinical features and long-term outcome of Hodgkin Lymphoma in Sri Lanka

DOI: 10.1016/j.eclinm.2021.100998

Year: 2021

Urinary leukotrienes and histamine in patients with varying severity of acute dengue.

DOI: 10.1371/journal.pone.0245926

Year: 2021

‘Why are you not dead yet?’ – dimensions and the main driving forces of stigma and discrimination among COVID-19 patients in Sri Lanka

DOI: 10.1016/j.puhe.2021.07.001

Year: 2021

Transcriptomics of acute DENV-specific CD8+ T cells does not support qualitative differences as drivers of disease severity.

DOI: 10.1101/2021.09.01.21262833

Year: 2021

Comparison of kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222

DOI: 10.1101/2021.07.14.21260510

Year: 2021

Emergence of a Dengue virus serotype 2 causing the largest ever 2 dengue epidemic in Sri Lanka 3 4 Short title : Dengue serotype 2 causing a large outbreak in Sri Lanka 5

DOI:

Year: 2021

What Is the Relationship Between Climate Change and Food Security?

What is the Impact of Co-Infection on Public Health?

What is Viral Mutation and Why is it Important?

What Are Functional Assays?

How Can STIs Be Prevented?

What Are the Challenges in Controlling Dengue?

What is Cervical Cancer?

What are the Global Statistics on Infectious Disease Mortality?

How to Apply Insect Repellent Effectively?

What are Antiparasitics?

Partnered Content Networks

Relevant Topics